Bolder Surgical→Hologic
Acquisition · Cash · HOLX · announced Oct 14, 2021
Announced
Oct 14, 2021
Closed
Nov 29, 2021
Economics
Cash()
Pre-deal · pre-deal mark: 2021, year precision · rounding grid ±$100M · Hologic press release — Bolder Surgical acquisition, 2021
~$160M subject to working capital adjustments
Target
Bolder Surgical
Gynecological Surgery · Clinical / therapeutic
HQ Louisville, CO · Founded 2012
Advanced energy vessel sealing surgical devices (CoolSeal, JustRight) for laparoscopic and open procedures — used in OB/GYN, pediatric surgery
- Nasdaq — Hologic press release (Oct 14, 2021)
- SEC EDGAR — Hologic 10-K FY2022 (purchase price allocation)
Acquirer
Hologic (HOLX)
Breast Health
HQ Marlborough, MA
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
CoolSeal vessel sealing devices expand laparoscopic GYN surgery portfolio — Hologic estimates 5× more laparoscopic procedures in OB/GYN vs. pediatrics (Bolder's prior focus)
Evidence ladder
Secondary (press / IR)
Nasdaq — Hologic press release (Oct 14, 2021)
Primary (regulatory / filing)
SEC 10-K FY2022
SEC EDGAR filings (ticker locator)
Limitations
- ~$160M subject to working capital adjustments
- Pre-deal valuation sourced from: Hologic press release — Bolder Surgical acquisition, 2021. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Gynecological Surgery
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Acessa Health | Hologic | Aug 25, 2020 | same evidence class · same acquirer | |
| Gynesonics | Hologic | Sep 15, 2024 | same evidence class · same acquirer | |
| obp Surgical | CooperSurgical (CooperCompanies) | Aug 1, 2024 | same evidence class |
Other verified deals by Hologic
Acquirer program history not already listed as a valuation peer or adjacency row.
| Target | Acquirer | Announced | Value | Sector |
|---|---|---|---|---|
| Endomagnetics | Hologic | May 20, 2024 | Breast Health | |
| Biotheranostics | Hologic | Jan 5, 2021 | Breast Health | |
| SuperSonic Imagine | Hologic | Jun 21, 2019 | Breast Health | |
| Focal Therapeutics | Hologic | Sep 26, 2018 | Breast Health | |
| Faxitron Bioptics | Hologic | Jul 31, 2018 | Breast Health |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Bolder Surgical (Gynecological Surgery). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.